Can people with anxiety and depression who have insomnia not receive compound betamethasone injections?

People with anxiety disorder, depression, and insomnia can receive compound betamethasone injections, but must do so cautiously. This medication is a corticosteroid; although it is not strictly contraindicated for such individuals, it may affect mood and sleep. Its use should be evaluated based on individual medical conditions and administered only under medical supervision. If anxiety, depression, or insomnia worsens after administration, prompt medical consultation is advised.

The primary effects of compound betamethasone are anti-inflammatory and anti-allergic, and it is clinically used to treat rheumatic autoimmune diseases, skin inflammations, and similar conditions. Its pharmacological action does not directly conflict with anti-anxiety or antidepressant medications, so it is not an absolute contraindication for these patients.

However, corticosteroids may affect the central nervous system. Some individuals may experience mood swings, irritability, or worsened insomnia after taking the drug. Given that patients with anxiety and depression already have heightened sensitivity regarding mood and sleep, corticosteroid use could potentially trigger or exacerbate symptoms. Therefore, treatment should only proceed when benefits clearly outweigh the risks, following strict clinical evaluation.

During treatment, maintain regular sleep patterns and avoid staying up late to reduce further strain on sleep. Eat a light, non-irritating diet, engage in moderate, gentle exercise to help regulate mood, closely monitor your physical and mental condition, and continue using prescribed anti-anxiety or antidepressant medications as directed by your doctor.